Americans who have taken COVID vaccine shots and those who have refused to capitulate to the coercion and propaganda are
truthbasedmedia.com
From Shots to Clots: Science Shows COVID Vaccines Cause Blood Clots
by
DR. JOEL S. HIRSCHHORN
August 7, 2021
Americans who have taken COVID vaccine shots and those who have refused to capitulate to the coercion and propaganda are ill-informed about blood clots.
This article provides summaries of key recently published research on two types of observed blood clots – microscopic and relatively large size – that merit serious attention and concern.
One inevitable conclusion is that the FDA with support from big media is not doing its job to ensure truly informed consent by those taking vaccine shots.
Canadian physician reports high levels of clots
Dr Charles Hoffe has been practicing medicine for 28 years in a small, rural town in British Columbia, Canada, and recently gave a
long interview. He has given about 900 doses of the Moderna experimental mRNA vaccine to his patients. So, contrary to some critics, he is no anti-vaccine doctor.
The core problem he has seen are microscopic clots in his patients’ tiniest capillaries. He said “Blood clots occurring at a capillary level. This has never before been seen. This is not a rare disease. This is an absolutely new phenomenon.”
Most importantly, he has emphasized these micro-clots are too small to show up on CT scans, MRI, and other conventional tests, such as angiograms, and can only be detected using the D-dimer blood test. Using the latter, he found that 62% of his patients injected with an mRNA shot are positive for clotting. He has explained what is happening in bodies.
The spike proteins in the vaccine become “part of the cell wall of your vascular endothelium. This means that these cells which line your blood vessels, which are supposed to be smooth so that your blood flows smoothly now have these little spikey bits sticking out. … when the platelet comes through the capillary it suddenly hits all these COVID spikes and it becomes absolutely inevitable that blood clots will form to block that vessel.”
He made an important distinction: “The blood clots we hear about which the media claim are very rare are the big blood clots which are the ones that cause strokes and show up on CT scans, MRI, etc. The clots I’m talking about are microscopic and too small to find on any scan. They can thus only be detected using the D-dimer test…The most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot re-generate. When those tissues are damaged by blood clots they are permanently damaged.”
This is his pessimistic, scientific view: “blood vessels in their lungs are now blocked up. In turn, this causes the heart to need to work harder to try to keep up against a much greater resistance trying to get the blood through your lungs.
This is called pulmonary artery hypertension – high blood pressure in the lungs because the blood simply cannot get through effectively. People with this condition usually die of heart failure within a few short years.”
All these medical views have been suppressed by big media., but it was covered well in another
alternative news site. And the doctor got some attention by submitting an
open letter to the provincial Ministry of Health. A key point in that is this: “It must be emphasised, that these people were not sick people, being treated for some devastating disease.
These were previously healthy people, who were offered an experimental therapy, with unknown long-term side-effects, to protect them against an illness that has the same mortality rate as the flu. Sadly, their lives have now been ruined.”
The concept of micro blood clots has also been invoked for the serious impacts of COVID itself. The eminent Dr. Peter McCullough
noted “So, this is a very different type of blood clotting that we would see with major blood clots in the arteries and veins. For instance, blood clots involved in stroke and heart attack.
Blood clots involved in major blood vessels in the legs. This was a different type of clotting and in fact the Italians courageously did some autopsies and found micro blood clots in the lungs. And so, we understood in the end, the reason why the lungs fail is not because the virus is there. It is because micro blood clots are there. … When People can’t breathe, the problem is micro-blood clotting in the lungs. …The spicule on the ball of the of the virus itself which damages blood vessels that causes blood clotting.” He has also openly stated that none of the COVID vaccines are safe for most people at little risk from COVID.
If spike protein is the cause of micro blood clots in COVID it is also reasonable to see the same phenomenon in vaccinated people impregnated with spike proteins, as Dr. Hoffe as explained.
As to the Canadian situation, The Public Health Agency of Canada (PHAC) in July estimated the rate of vaccine-related blood clotting in Canadians who have received the AstraZeneca vaccine and said there have been 27 confirmed cases to date in Canada, with five deaths among those cases, a rather high death rate.
But this is consistent with 6 out of 28 blood clot cases
reported by Yale University for the J&J vaccine in the US Also noted was that these were a particularly rare and dangerous blood clot in the brain, known as cerebral venous sinus thrombosis (CVST), because it appears in the brain’s venous sinuses Also noted that there were abnormally low platelet levels in their blood, an unusual situation also found for those impacted by the AstraZeneca vaccine.
Wall Street Journal and Nature Journal
To its credit, the Wall Street Journal published a
long article in July on the COVID vaccine blood clot issue. Here are highlights from it.
“Canadian researchers say they have pinpointed a handful of amino acids targeted by key antibodies in the blood of some people who received the AstraZeneca Covid-19 vaccine, offering fresh clues to what causes rare blood clots associated with the shot.”
“The peer-reviewed findings, by a team of researchers from McMaster University in Ontario, were published …by the
science journal Nature. They could help doctors rapidly test for and treat the unusual clotting, arising from an immune-driven mix of coagulation and loss of platelets that stop bleeding.”
“The blood clotting, which some scientists have named vaccine-induced immune thrombotic thrombocytopenia, or VITT, has also been linked to Johnson & Johnson’s Covid-19 shot, though incidents have occurred less frequently with that shot than with AstraZeneca.”
“Though rare, the condition has proven deadly in more than 170 adults post-vaccination in the U.K., Europe and U.S., according to government tallies. Many were younger adults who appeared healthy before vaccination, researchers and drug regulators say.”
“The total number of cases after first or second doses in the U.K. was 395 through June 23…Of the 395, 70 people have died. European officials said this month that they have seen 479 potential cases of VITT out of 51.4 million AstraZeneca vaccinations…Far fewer potential cases—21 …followed J&J vaccinations in Europe. Of those cases, 100 deaths occurred after AstraZeneca vaccination and four after Johnson & Johnson, European regulators said.”
“U.S. health officials said in late June that they have identified 38 confirmed cases of the blood-clotting syndrome out of more than 12.3 million people who received the J&J vaccine…The Centers for Disease Control and Prevention said in May that three cases had been fatal and evidence ‘suggests a plausible causal association’ between the combination of low platelets and clotting and the vaccine.”
As to what is going on inside the body: “[In] rare cases, vaccinated people have experienced an autoimmune reaction in which antibodies bind with unusual strength to a blood component called platelet factor 4, or PF4, forming distinct clusters resembling a bunch of grapes. This so-called immune complex, a molecular formation in the blood, activates more platelets, ‘like putting a match to gasoline,’ said John Kelton, an author of the Nature paper and researcher at McMaster University.
The process accelerates, he and other researchers say, triggering simultaneous bleeding and clotting, sometimes in the brain, stomach and other areas that can in rare cases be deadly. ‘We think these antibodies are incredible amplifiers, in a bad way, of the normal coagulation system,’ says Dr. Kelton”
Interestingly, this article did not mention at all the previously discussed case of the Canadian doctor and his findings about microscopic blood clotting.
New York Times
In April, there was limited
coverage of stoppages of some vaccines: “First it was AstraZeneca. Now Johnson & Johnson. Last week, British regulators and the European Union’s medical agency said they had established a possible link between AstraZeneca’s Covid-19 vaccine and very rare, though sometimes fatal, blood clots.
The pause in the use of Johnson & Johnson’s vaccine in Europe over similar concerns threatens to hurt a sluggish rollout that was just starting to gain momentum.” Also noted was that states paused use of the J&J vaccine after a US advisory.
“Regulators have asked vaccine recipients and doctors to look out for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin.”
New England Journal of Medicine
In April this journal published three research articles on blood clotting related to COVID vaccines and a long
editorial by two physicians reviewing all the work.
Here are highlights from the latter.
“The Journal has now highlighted three independent descriptions of 39 persons with a newly described syndrome characterized by thrombosis and thrombocytopenia that developed 5 to 24 days after initial vaccination with [the AstraZeneca vaccine]. … These persons were healthy or in medically stable condition, and very few were known to have had previous thrombosis or a preexisting prothrombotic condition.
Most of the patients included in these reports were women younger than 50 years of age, some of whom were receiving estrogen-replacement therapy or oral contraceptives. A remarkably high percentage of the patients had thromboses at unusual sites — specifically, cerebral venous sinus thrombosis or thrombosis in the portal, splanchnic, or hepatic veins. Other patients presented with deep venous thrombi, pulmonary emboli, or acute arterial thromboses. …
High levels of d-dimers and low levels of fibrinogen were common and suggest systemic activation of coagulation. Approximately 40% of the patients died, some from ischemic brain injury, superimposed hemorrhage, or both conditions, often after anticoagulation.”
“Better understanding of how the vaccine induces these platelet-activating antibodies might also provide insight into the duration of antigen exposure and the risk of reoccurrence of thrombosis, which will inform the need for extended anticoagulation and might lead to improvements in vaccine design.”
“Additional cases have now been reported to the European Medicines Agency, including at least 169 possible cases of cerebral venous sinus thrombosis and 53 possible cases of splanchnic vein thrombosis among 34 million recipients of the [AstraZeneca] vaccine, 35 possible cases of central nervous system thrombosis among 54 million recipients of the Pfizer–BioNTech mRNA vaccine, and 5 possible (but unvetted) cases of cerebral venous sinus thrombosis among 4 million recipients of the Moderna mRNA vaccine. Six possible cases of cerebral venous sinus thrombosis (with or without splanchnic vein thrombosis) have been reported among the more than 7 million recipients of the Johnson & Johnson/Janssen vaccine.”
Here is the final conclusion; “The questions of whether certain populations can be identified as more suitable candidates for one or another vaccine and who and how to monitor for this rare potential complication will require additional study.”
Part 1 of 2